Chargement

Slzii.com Recherche

Recherche (Nouvelles)

Wedbush Raises Xenon Price Target To $71; Azetukalner NDA Filing Expected In Q3 2026

Rttnews english business

Wedbush analyst Laura Chico on Friday reiterated an Outperform rating on Xenon Pharmaceuticals Inc. (XENE), a neuroscience-focused biopharmaceutical company, and lifted the price target to $71 from $63.
2026-08-10 09:47:16

Que fais-tu?
0.011245965957642


Nouvelles
Nouvelles

Dernières nouvelles et titres
Wedbush analyst Laura Chico on Friday reiterated an Outperform rating on Xenon Pharmaceuticals Inc. (XENE), a neuroscience-focused biopharma...
Nouvelles